Oostenrijk - Duits - AGES (Agentur für Gesundheit und Ernährungssicherheit)

baxter healthcare gmbh - ifosfamid - nitrogen mustard analogue

Singapore - Engels - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - ifosfamide - injection, powder, for solution - 1 g/25 ml - ifosfamide 1 g/25 ml

Australië - Engels - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - ifosfamide, quantity: 500 mg - injection, powder for - excipient ingredients: - use in the treatment of tumours sensitive to ifosfamide either as a single agent or in combination with other chemotherapeutic agents. tumour types that have been demonstrated to respond to ifosfamide single agent or in combination are germ cell tumours, sarcomas, lymphomas. anti-tumour activity has been shown in ovarian and cervical cancers. some activity has also been seen in lung and breast cancer.

Bulgarije - Bulgaars - Изпълнителна агенция по лекарствата

baxter oncology gmbh. - Ифосфамид - 500 mg powder for solution for infusion

Bulgarije - Bulgaars - Изпълнителна агенция по лекарствата

baxter oncology gmbh. - Ифосфамид - 1 g powder for solution for infusion

Bulgarije - Bulgaars - Изпълнителна агенция по лекарствата

baxter oncology gmbh. - Ифосфамид - 2 g powder for solution for infusion

Australië - Engels - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - ifosfamide -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - ifosfamide -

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - ifosfamid - pulver til injektions-/infusionsvæske, opløsning - 1 g

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - ifosfamid - pulver til injektions-/infusionsvæske, opløsning - 2 g